N-Methyl diethanolamine (MDEA) is an organic compound used as an amine gas treating solvent in natural gas treatment and carbon capture applications. It is a tertiary amine used for removing acid gases such as hydrogen sulfide and carbon dioxide from natural gas and synthesis gases. N-MDEA has high volatility and can absorb more carbon dioxide from flue gases than other amines, making it a preferred choice for commercial carbon capture applications.
The Global N-Methyl Diethanolamine (MDEA) Market Size is estimated to be valued at US$ 773.71 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2030. Growing demand from natural gas processing plants and increasing focus on reducing CO2 emissions drive the market.
Key Takeaways
Key players operating in the N-Methyl Diethanolamine (MDEA) are GlaxoSmithKline plc, Novartis AG, Pfizer Inc., AstraZeneca plc, Boehringer Ingelheim International GmbH, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Sanofi S.A., Sunovion Pharmaceuticals Inc., Mylan N.V., Cipla Ltd., Grifols S.A., Insmed Incorporated, Arbor Pharmaceuticals LLC. The increasing usage of MDEA in gas processing applications such as removal of H2S and CO2 from natural gas and synthesis gases is fueling market growth. Technological advancements are helping improve the efficiency and regeneration process of N-MDEA for increased CO2 absorption in carbon capture applications.
Market Trends
Government regulations to reduce CO2 emissions: Stringent government regulations regarding carbon emissions from industries are propelling growth in carbon capture technology. This is augmenting the demand for N-MDEA which is used as a solvent in post-combustion CO2 capture processes.
Increased investments in carbon capture projects: To meet climate targets, investments in commercial carbon capture projects using N-MDEA are rising. For instance, investments in the carbon capture, utilization, and storage sector witnessed a growth of 54% from 2019 to 2020.
Market Opportunities
Development of advanced CO2 capture technologies: Ongoing R&D to develop new solvent formulations based on MDEA that can capture CO2 at lower energy costs will open growth avenues.
Emerging economies boosting gas processing capacities: Rapid industrialization in Asian countries is spurring investments to expand natural gas processing facilities. This raises opportunities for N-MDEA suppliers as it is a preferred solvent for H2S and CO2 removal in gas treating units.
Impact of COVID-19 on N-Methyl Diethanolamine (MDEA) Market Growth
The COVID-19 pandemic has adversely impacted the growth of N-Methyl Diethanolamine (MDEA) market across the globe. The lockdowns enforced to curb the spread of the virus led to temporary shutdown of major end-use industries such as oil & gas, chemicals, power generation among others which stalled the demand for MDEA. Strict travel restrictions and supply chain disruptions led to decline in global trade activities further dampening the market growth. Many construction and infrastructure projects were put on hold which affected the consumption of MDEA in such applications. However, with lifting of lockdowns and resumption of economic activities post pandemic, the MDEA market is expected to gradually recover over the forecast period. The oil & gas industry is anticipated to drive the demand as it rebounds from the crisis. Initiatives towards infrastructure modernization and expansion of manufacturing capacities would further support market growth in coming years. Continuous R&D efforts for development of bio-based and environment friendly MDEA products is likely to open new opportunities. However, volatile feedstock prices remain a challenge going forward.
Geographically, North America dominates the global N-Methyl Diethanolamine (MDEA) market in terms of value. This is attributed to large presence of oil & gas industry and major MDEA producers in the region. The US accounts for largest share driven by increasing shale gas production, growing refining capacities and infrastructural advancement initiatives. Europe and Asia Pacific are estimated as fastest growing regional markets supported by rising energy demand, progressive industrialization and investments in green energy sector in countries like China and India. Latin America and Middle East & Africa also present lucrative prospects for MDEA vendors owing to rapid industrialization along with expansion of oil & gas exploration activities especially in Brazil, Venezuela and Saudi Arabia.
Fastest growing region for N-Methyl Diethanolamine (MDEA) market is Asia Pacific supported by robust economic growth, rapid urbanization and increasing investments in core industries across emerging nations. China and India dominate regional consumption attributed to sharp rise in manufacturing activities and strong development of oil & gas infrastructure. With growing population and improving living standards, energy demand in Asia Pacific is projected to increase substantially over the next decade. This offers widespread application avenues for MDEA used in natural gas processing and treatment of industrial waste streams. Government initiatives to expand renewable energy capacity through investments in biofuels and carbon capture technology would further propel MDEA demand. Investments by major end-users towards capacity additions also lend momentum to regional market growth outlook.
Get More Insights on This Topic: https://www.pressreleasebulletin.com/n-methyl-diethanolamine-mdea-market-trends-growth-and-regional-outlook-2024-2030/
When n-Methyl Diethanolamine (MDEA) causes muscular contraction, it causes a chemical reaction within the cells that dilates blood vessels, increasing blood flow to that specific muscle.
The increased blood flow generates a transient rise in body temperature, which leads to greater metabolic activity.
The methyl diethanolamine chemical's impact isn't unique; it's been discovered in a number of natural gas treatments, including the popular gas treatment.
Because of how easily it is taken into the human body and because it was thought to be safer than the chlorinated natural gases generated by chlorination, this chemical was chosen for gas treatment.
N-Methyl Diethanolamine (MDEA), on the other hand, has been linked to cancer and has been prohibited by the government.The goal of n-Methyl Diethanolamine (MDEA) is to provide a safe and affordable alternative to tetrasodium Ethylenediaminetetraacetic acid, which is very poisonous and dangerous (EDTA).
It has also been discovered that trace levels of N-methyl diethanolamine are present in certain popular bottled distilled water products.
The global N-Methyl-2-Pyrrolidone Market report offers a comprehensive assessment of the market for the forecast years.
This globe industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.The key market players for the global N-Methyl-2-Pyrrolidone market are listed below:BASFYuneng ChemicalAshlandMitsubishi ChemicalMYI ChemicalLondellbasellGuangming ChemicalsSynmiway ChemicalEastmanGanzhou ZhongnengRuian ChemicalSNETCNSGOthersClick here to get a FREE Sample Copy of the N-Methyl-2-Pyrrolidone Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-25122The Global N-Methyl-2-Pyrrolidone Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.COVID-19 Impact Analysis on N-Methyl-2-Pyrrolidone MarketThe global pandemic COVID-19 has affected the N-Methyl-2-Pyrrolidone market directly or indirectly.
The detailed study highlights the probable outcomes of this global crisis on the N-Methyl-2-Pyrrolidone industry.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?
